COMPANIES COVERED
TakedaDownload FREE Report Sample
Download Free sampleThrombin?is a serine protease, an enzyme that, in humans, is encoded by the F2 gene.
Thrombin Market contains market size and forecasts of Thrombin in global, including the following market information:
Global Thrombin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Thrombin Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Thrombin companies in 2021 (%)
The global Thrombin market was valued at 581.3 million in 2021 and is projected to reach US$ 715.7 million by 2028, at a CAGR of 3.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Form Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Thrombin include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer and Octapharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Thrombin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thrombin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Thrombin Market Segment Percentages, by Type, 2021 (%)
Powder Form
Solution Form
Pad Form
Spray Kits
Others
Global Thrombin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Thrombin Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostics & Clinics
Academic and Research Institute
Global Thrombin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Thrombin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thrombin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Thrombin revenues share in global market, 2021 (%)
Key companies Thrombin sales in global market, 2017-2022 (Estimated), (MT)
Key companies Thrombin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies Inc.
Pfizer
Octapharma
Omrix Biopharmaceuticals Ltd.
Shanghai RAAS
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
